Hypertension
Showing NaN - NaN of 82
Hypertension Trial in United States (Anti-hypertensive therapy, No anti-hypertensive therapy (unless BP is severe))
Completed
- Hypertension
- Anti-hypertensive therapy
- No anti-hypertensive therapy (unless BP is severe)
-
Birmingham, Alabama
- +71 more
Dec 16, 2022
Hypertension, Chronic Kidney Diseases Trial in Houston (n-of-1 trial guided clinical decision making)
Completed
- Hypertension
- Chronic Kidney Diseases
- n-of-1 trial guided clinical decision making
-
Houston, TexasUniversity of Texas at Houston Medical School; Pediatric Nephrol
Nov 1, 2022
Hypertension Trial in Worldwide (Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg, telmisartan 40 mg/amlodipine 5
Recruiting
- Hypertension
- Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg
- +7 more
-
Phoenix, Arizona
- +84 more
Aug 19, 2022
Chronic Kidney Disease, Hypertension Trial in Houston (Diuretic augmentation (hydrochlorothiazide, chlorthalidone, furosemide,
Not yet recruiting
- Chronic Kidney Disease
- Hypertension
- Diuretic augmentation (hydrochlorothiazide, chlorthalidone, furosemide, torsemide, or bumetanide)
-
Houston, TexasMichael E. DeBakey VA Medical Center, Houston, TX
Aug 3, 2022
Obesity, Hypertension, Diabetes, Type 2 Trial in United States (Overstitch)
Completed
- Obesity
- +2 more
- Overstitch
-
Orlando, Florida
- +8 more
Mar 14, 2022
Samples From Pregnant Evaluation of Preeclampsia Biomarkers
Completed
- Preeclampsia
- +6 more
-
Birmingham, Alabama
- +19 more
Mar 10, 2022
Diabetes, Type 2, Hypertension Trial in Houston (Motivational interviewing intervention arm)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Hypertension
- Motivational interviewing intervention arm
-
Houston, TexasOmar Serna
Sep 27, 2021
Diabetes, Hyperlipidemia, Hypertension Trial in United States (CVRS Intervention)
Completed
- Diabetes
- +3 more
- CVRS Intervention
-
Gainesville, Florida
- +17 more
Jul 22, 2021
Hypertension Trial in Worldwide (Azilsartan Medoxomil, Losartan, Placebo for Azilsartan Medoxomil)
Completed
- Hypertension
- Azilsartan Medoxomil
- +4 more
-
Anaheim, California
- +68 more
Feb 10, 2021
Dyslipidemia, Hypertension Trial in United States (Amlodipine besylate, Amlodipine besylate/atorvastatin calcium single pill
Completed
- Dyslipidemia
- Hypertension
- Amlodipine besylate
- Amlodipine besylate/atorvastatin calcium single pill combination
-
Birmingham, Alabama
- +50 more
Jan 26, 2021
Hypertension, Dyslipidemia Trial in United States (Amlodipine/Atorvastatin)
Completed
- Hypertension
- Dyslipidemia
-
Birmingham, Alabama
- +105 more
Jan 26, 2021
Dyspnea, Hypertension, Acute Heart Failure Trial in United States (Stage 1: Clevidipine (double-blinded), Stage 1: Placebo
Withdrawn
- Dyspnea
- +2 more
- Stage 1: Clevidipine (double-blinded)
- +3 more
-
Montgomery, Alabama
- +8 more
Oct 12, 2020
Hypertension Trial in United States (Nebivolol with concomitant losartan or lisinopril, HCTZ with concomitant losartan or
Completed
- Hypertension
- Nebivolol with concomitant losartan or lisinopril
- +2 more
-
Athens, Alabama
- +87 more
Feb 13, 2020
Hypertension Trial in Dominican Republic, United States (metoprolol succinate)
Completed
- Hypertension
- metoprolol succinate
-
Little Rock, Arkansas
- +30 more
Jan 14, 2020
Drug-Induced Nephropathy, Hypertension, Proteinuria Trial in Houston (Arginine, Placebo)
Withdrawn
- Drug-Induced Nephropathy
- +2 more
- Arginine
- Placebo
-
Houston, TexasM D Anderson Cancer Center
May 17, 2019
Hypercholesterolemia, Hypertension Trial in United States (ETC-1002, Placebo)
Completed
- Hypercholesterolemia
- Hypertension
- ETC-1002
- Placebo
-
Birmingham, Alabama
- +34 more
Mar 26, 2019